Clinical Trial Update: Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome [Phase 2, Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 2/3 efficacy and safety study evaluating ecabet ophthalmic solution for dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Ecabet Ophthalmic Solution (ecabet)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye Syndromes | Phase 2, Phase 3 | Status: COMPLETED